Trial intelligence / Profile preview

Phase III Study of PLB1004 in EGFR Exon 20 Insertion Mutant NSCLC

ChiCTR2500107929Phase 3Recruiting

Sponsor

Guangdong Provincial People's Hospital

Start

Aug 2025

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1